Loading company…
PL BioScience develops Human Platelet Lysate products for research, diagnostics, and regenerative medicine.
Founded in 2015 and based in Aachen, Germany, PL BioScience develops and commercializes Human Platelet Lysate products under the ELAREM™ brand. Its products are intended for academic research, diagnostics, and regenerative medicine as alternatives to traditional cell culture supplements. In April 2024, it raised EUR 7.8 million in Series A funding from TechVision and Brightlands Venture.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in